A Long-Awaited Triumph: Africa Embarks on the Rollout of the World's First Malaria Vaccine
New Malaria Vaccine Reaches Africa, But Hurdles Linger
DOI:
https://doi.org/10.62807/jowach.v1i1.2023.1-3Keywords:
immunization, malaria, africa, children, underfive, prevention, news, global health, public health, child health, maternal healthAbstract
After decades of relentless pursuit, a beacon of hope shines brightly across Africa as the continent commences the widespread rollout of RTS,S, the first-ever licensed vaccine against the deadly malaria parasite. This historic immunization campaign marks a new era in the fight against a disease that claims hundreds of thousands of lives in Africa each year, disproportionately impacting young children under five.
The approval of RTS,S caps over 30 years of tireless research and development, much of it spearheaded by African scientists. While not a silver bullet, experts agree the vaccine will provide meaningful protection when incorporated alongside existing measures like insecticide-treated nets. Its launch represents a major milestone for African nations at the forefront of deploying this innovative tool to combat an ancient foe.
References
No References
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Women and Child Health
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Women and Child Health (JoWaCH) adheres to the CC BY 4.0 license, which is a Creative Commons Attribution 4.0 International License. For comprehensive information, we kindly request that you refer to the full license legal code. JoWaCH employs a non-exclusive license agreement for the purpose of open-access publication. In the context of open access publishing, the authors maintain the copyright of their work while also granting the journal the rights to publish and distribute it, while retaining the primary academic use rights. This practice facilitates the optimal use and dissemination of the work, while also guaranteeing proper attribution to the original source. The handling of manuscript content shall be conducted with confidentiality, with the exception of cases involving review processes and investigations related to potential misconduct, plagiarism, and duplicate/redundant or overlapping publications, in accordance with the guidelines provided by the Committee on Publication Ethics (COPE) COPE Guidelines.
JoWaCH is prohibited from disseminating content derived from previously published scientific work without obtaining proper authorization. Obtaining permission from the copyright holder, who may be either the author(s) or the publisher, is necessary in cases where the copyright holder is the publisher, for any work you want to use.
While it is acceptable to use a small amount of a work, obtaining permission from the copyright owners is necessary for a significant extraction.
The use of unmodified or little modified tables, graphs, and artworks (whether they are the user's own work previously published elsewhere or created by another copyright holder) necessitates obtaining permission.
Tables, graphs, charts, and artworks that have been fully redesigned and rebuilt, and include proper reference of the source, do not need obtaining permission.
JoWaCH facilitates unrestricted access to journal material for readers, necessitating the imposition of membership fees. The journal operates on a self-sustaining financial model and does not rely on support from other sources. The procedure of publishing is contingent only upon the financial resources of the publisher. The readers have unrestricted access to the information on the journal website.
